<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND:: Idiopathic <z:hpo ids='HP_0002343'>normal pressure hydrocephalus</z:hpo> (iNPH) causes <z:hpo ids='HP_0001268'>cognitive decline</z:hpo> that can be alleviated by shunting, but long-term outcome studies are scarce </plain></SENT>
<SENT sid="1" pm="."><plain>OBJECTIVE:: To elucidate the long-term cognitive condition of shunt-responsive iNPH patients </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS:: The follow-up data (Kuopio University Hospital <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NPH</z:e> Registry) of 146 patients diagnosed with iNPH by clinical and radiological examination, 24-hour intraventricular pressure monitoring, frontal cortical biopsy, and response to the shunt were analyzed for signs of <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>The <z:chebi fb="4" ids="38624">DSM</z:chebi>-IV and specified <z:e sem="disease" ids="C0025261" disease_type="Mental or Behavioral Dysfunction" abbrv="">memory disorder</z:e> criteria were used </plain></SENT>
<SENT sid="4" pm="."><plain>Median follow-up was 4.8 years </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS:: At the end of follow-up, 117 (80%) of the 146 iNPH patients had <z:hpo ids='HP_0001268'>cognitive decline</z:hpo> and 67 (46%) clinical <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>The most common clinical diagnoses were <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> and vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>In multivariate analysis of the 146 iNPH patients, <z:e sem="disease" ids="C0233794" disease_type="Mental or Behavioral Dysfunction" abbrv="">memory deficit</z:e> as a first symptom prior to shunt (OR 18.3; 95% CI 1.9-175), male gender (OR 3.29; 95% CI 1.11-9.73), age (OR 1.17/year 95% CI 1.07-1.28), and follow-up time (OR 1.20/year 95% CI 1.02-1.40) predicted <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>Interestingly, eight (5%) iNPH patients had <z:hpo ids='HP_0000726'>dementia</z:hpo> without any signs of other <z:hpo ids='HP_0002180'>neurodegenerative diseases</z:hpo> in clinical, neuroradiological, or brain biopsy evaluation </plain></SENT>
<SENT sid="9" pm="."><plain>These patients initially presented a full triad of symptoms, with <z:hpo ids='HP_0001288'>gait disturbance</z:hpo> being the most frequent initial symptom followed by deterioration in cognition </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSION:: The novel findings were: (a) a significant risk of <z:hpo ids='HP_0000726'>dementia</z:hpo> in iNPH initially responsive to CSF shunt; (b) <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo> most commonly due to iNPH-related <z:hpo ids='HP_0000726'>dementia</z:hpo> followed by concurrent degenerative <z:e sem="disease" ids="C0006111" disease_type="Disease or Syndrome" abbrv="">brain disease</z:e>; and (c) a subgroup with <z:hpo ids='HP_0000726'>dementia</z:hpo> related to iNPH without comorbidities </plain></SENT>
</text></document>